Javier Sanchez Perona

Dr. Javier Sanchez Perona

Department of Food and Health, Instituto de la Grasa‐CSIC (CSIC), Campus of the University Pablo de Olavide, 41013 Seville, Spain
orcid

Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2010 in Nutrition, Metabolism and Cardiovascular Diseases
Verified
Journal Article
Closed access
JLJosé López-Miranda
José López-Miranda
CMCarmen Marin
Carmen Marin
EREmilio Ros
Emilio Ros
RCR. De Caterina
R. De Caterina
Lina BadimonLina Badimon
Lina Badimon
NYN. Yiannakouris
N. Yiannakouris

31 January 2022 in Nutrients
Verified
Journal Article
Open access
PDF file
JCJosé María Castellano
José María Castellano
Sara Ramos-RomeroSara Ramos-Romero
Sara Ramos-Romero
Javier Sanchez PeronaJavier Sanchez Perona
Javier Sanchez Perona
Oleanolic acid, a pentacyclic triterpenoid ubiquitously present in the plant kingdom, is receiving outstanding attention from the scientific community due to its biological activity against multiple diseases. Oleanolic acid is endowed with a wide range of biological activities with therapeutic potential by means of complex and multifactorial mechanisms. There is evidence suggesting that oleanolic acid might be effective against dyslipidemia, diabetes and metabolic syndrome, through enhancing insulin response, preserving the functionality and survival of β-cells and protecting against diabetes complications. In addition, several other functions have been proposed, including antiviral, anti-HIV, antibacterial, antifungal, anticarcinogenic, anti-inflammatory, hepatoprotective, gastroprotective, hypolipidemic and anti-atherosclerotic activities, as well as interfering in several stages of the development of different types of cancer; however, due to its hydrophobic nature, oleanolic acid is almost insoluble in water, which has led to a number of approaches to enhance its biopharmaceutical properties. In this scenario, the present review aimed to summarize the current knowledge and the research progress made in the last years on the extraction and characterization of oleanolic acid and its biological activities and the underlying mechanisms of action.

18 April 2007 in European Journal of Clinical Nutrition
Verified
Journal Article
Closed access
PDF file
Jordi Salas-SalvadóJordi Salas-Salvadó
Jordi Salas-Salvadó
AGA Garcia-Arellano
A Garcia-Arellano
RER Estruch
R Estruch
FMF Marquez-Sandoval
F Marquez-Sandoval
DCD Corella
D Corella
FIfor the PREDIMED Investigators
for the PREDIMED Investigators

1 July 2006 in The Journal of Nutritional Biochemistry
Verified
Journal Article
Closed access
Javier Sanchez PeronaJavier Sanchez Perona
Javier Sanchez Perona
RCRosana Cabello-Moruno
Rosana Cabello-Moruno
VRValentina Ruiz-Gutierrez
Valentina Ruiz-Gutierrez

1 October 2004 in British Journal of Nutrition
Verified
Journal Article
Closed access
PDF file
Rosalía Rodriguez RodriguezRosalía Rodriguez Rodriguez
Rosalía Rodriguez Rodriguez
MHMaría Dolores Herrera
María Dolores Herrera
Javier Sanchez PeronaJavier Sanchez Perona
Javier Sanchez Perona
VRValentina Ruiz-Gutiérrez
Valentina Ruiz-Gutiérrez
‘Orujo’ olive oil is obtained by chemical processes from the waste resulting from the mechanical extraction of virgin olive oil. The aim of the present study was to evaluate a new pharmacological property of two natural triterpenoids contained in olive oil, as vasodilatory agents, and to determine their mechanism of action. The two compounds studied were oleanolic acid and erythrodiol. The vasorelaxant effect induced by these pentacyclic triterpenoids was studied in isolated thoracic rat aorta. Oleanolic acid and erythrodiol, accumulatively added, showed vasorelaxant activities in aortic rings with endothelium pre-contracted by 10−6M-phenylephrine (maximum percentage of relaxation 86·38 (SEM 2·89) and 73·53 (SEM 6·01), respectively). They had almost no relaxant effect on depolarised or endothelium-denuded aortic segments. The relaxation was significantly attenuated by pre-treatment with the NO synthase inhibitor Nω-nitro-L-arginine-methylester (L-NAME; 3×10−4m). To characterise the involvement of endothelial factors, in addition to NO, arteries with endothelium were exposed to 10−5M-indomethacin (INDO), a cyclo-oxygenase inhibitor, or INDO plus L-NAME. INDO did not have any significant effect on the relaxant response of both compounds. The combination of L-NAME plus INDO only abolished the oleanolic acid-induced relaxation. The present results suggest that the mechanism of relaxation seems to be mainly mediated by the endothelial production of NO; however, other mechanisms cannot be excluded. It can be concluded that oleanolic acid and erythrodiol may have interesting therapeutic potential as new vasodilator drugs, thus protecting the cardiovascular system. Therefore, the intake of ‘orujo’ olive oil, as a source of these compounds, might be beneficial in this regard.

1 October 2004 in Clinical Nutrition
Verified
Journal Article
Closed access
Javier Sanchez PeronaJavier Sanchez Perona
Javier Sanchez Perona
JCJulio Cañizares
Julio Cañizares
EMEmilio Montero
Emilio Montero
JSJosé M Sánchez-Domínguez
José M Sánchez-Domínguez
ACAngel Catalá
Angel Catalá
VRValentina Ruiz-Gutiérrez
Valentina Ruiz-Gutiérrez